The Syneos Health Podcast: Conversations on Commercialization

At the Asembia 2026 Summit, Syneos Health host Chris Van Denburg sits down with Dale Lippert , Executive Director, CAR T Patient Support and Services at Autolus Therapeutics, to explore the operational realities behind CAR T patient support programs for relapsed/refractory acute lymphoblastic leukemia (ALL). Drawing on decades of experience launching CAR T therapies, Dale shares practical insights...

Recorded from the floor of Asembia 2026, this episode explores how biopharma leaders are rethinking reimbursement, patient access and commercial strategy in an increasingly complex market. Host Kim Plesnarski is joined by Brian Siemak , VP of Portfolio Strategy at MannKind, and Terry Milton , AVP Field Reimbursement at Eli Lilly, to continue their on-stage panel discussion on the mounting pressure...

Recorded on the ground at the Asembia Summit 2026, this episode explores how stronger collaboration, connected care models and patient-centered listening can improve access, affordability and outcomes in oncology care. Host Chris Van Denburg sits down with Micaila Ruiz, PharmD, MPH , Vice President, Clinical Operations, Pharmacy Care Services at Optum, to discuss the evolving role of specialty pha...

In this episode of Conversations on Commercialization , host Michael Sarshad, Managing Director, Consulting at Syneos Health, talks with KAI CEO David Williams and Deanne Melloy, CCO Deployment Solutions at Syneos Health, about how AI can help commercial teams improve call quality, coaching, field visibility and sales rep performance. They discuss why activity metrics fall short, how AI-enabled li...

In this episode,  Tyler Cowan , VP, Commercial speaks with Paul Rittman , President and General Manager of Almirall US, about how payer consolidation and PBM influence are reshaping dermatology commercialization.    They discuss how pharmaceutical companies must adapt launch strategy, market access planning and clinical differentiation to succeed in today’s competitive specialty landscape. The con...

What if drug naming could be faster, smarter and more aligned to brand strategy?  In this episode, Addison Whitney’s Joe Daley , President, and Bill Purdy , SVP and Managing Director of Global Brand Development & Strategy, break down how Ari ™ , a purpose-built AI platform, is solving long-standing naming and branding challenges in biopharma.  Listen and you’ll learn:   How Ari™ integrates str...

Recorded at Fierce Pharma Week 2025, the conversation continues with part two of our conversation with Mark Bard , co-founder of the Digital Health Coalition.  In this episode, Bard and host Tyler Cowan turn the lens to patients, exploring how direct-to-patient models are disrupting traditional care and the implications of reduced physician involvement. They also tackle the rise of agentic AI, wha...

Recorded at Fierce Pharma Week 2025, here is the first episode in a two-part series with Mark Bard , co-founder of the Digital Health Coalition.  In this episode, Bard joins host Tyler Cowan, VP, Commercial at Syneos Health to unpack how the pandemic reshaped provider expectations and the continued impact on commercial teams. From feedback loops to content fatigue, to the myth of multichannel mast...

Host Tyler Cowan , VP Commercial at Syneos Health, joins Hruta Shah , Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 therapies.  You’ll hear:  - What emerging launch strategies look like in a crowded pipeline and how success is being redefined  - How GLP-1s are accelerating a shift in stakeholder...

Recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad sits down with Kim Plesnarski , SVP of Market Access and Patient Support Services at Syneos Health and Kelly Carter , AVP of Patient Support at Amgen, to unpack the evolving landscape of patient support.  The discussion explores the blurring lines between general and specialty medicine, the growing administrative burden on pro...

In this episode of our Navigating Modern Market Access series, recorded from the floor of Asembia's AXS25 Summit, host Sara Rubin sits down with Rob Truckenmiller , the newly appointed CEO of PharmaCord.  Drawing from his deep experience across small, mid-sized and large pharmaceutical companies, Rob explores how market access strategies must evolve to meet today’s healthcare challenges. From...

In this episode, host Sara Rubin is joined by Cheryl Allen, RPh , founding partner at Curatio Advisors, to explore how manufacturers can evolve their access strategies in response to the growing complexity of specialty-like therapies. With a career spanning specialty pharmacy, digital health innovation and commercialization strategy, Cheryl shares how reframing these products as “enhanced retail”...

The biopharma market is booming—but not without turbulence. In this kickoff episode of our special podcast series in collaboration with Asembia, hosts Michael Sarshad , Managing Director, Commercial Advisory, Syneos Health and Sara Rubin , Senior Vice President, Market Access Strategy at Spherico, a Syneos Health company, unpack the dynamic forces reshaping how therapies reach patients. Recorded a...

In this special edition of the Syneos Health Podcast recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad speaks with Kim Plesnarski , SVP of Market Access and Patient Support Services at Syneos Health and Greg Morris , Chief Strategy Officer at CareMetx.  They explore the latest trends shaping patient support services—from the surge of AI-powered solutions to the shift toward h...

In this special episode recorded from the floor at Asembia’s AXS25 Summit, host Michael Sarshad sits down with Tiara Green , President of Accessia Health, to explore the evolving landscape of patient support.  They discuss how Accessia Health is addressing the growing needs of individuals with rare and chronic conditions—not just through copay assistance, but by tackling social determinants of hea...

Hosted by Drew Beck , Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and medical affairs to next-gen trial design, product launch strategies and the future of healthcare communications, each episode connects you with the minds driving real change. B...

2025 Health Trends meets The Syneos Health Podcast for a limited series exploring how Trends come alive in the life sciences industry with host Drew Beck , Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions. Syneos Health experts Brian Carver , Executive Director of Therapeutic Strategy and Innovation, Rare Disease Consortium, Vik Chawla , Managing Director, Syneos Health...

Hosted by Drew Beck , Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and medical affairs to next-gen trial design, product launch strategies and the future of healthcare communications, each episode connects you with the minds driving real change. B...

Commercialization decisions are shaping success earlier than ever in the product lifecycle, from value and access to launch strategy, deployment and stakeholder engagement. Conversations on Commercialization , a new spinoff of the Syneos Health Podcast, explores what this shift means for biopharma companies and what it takes to compete in a rapidly evolving market.  Led by Tyler Cowan, Commercial...